Top

Published in:

Open Access 01-12-2021 | Myalgie | Research article

Epidemiological characteristics and mortality risk factors among COVID-19 patients in Ardabil, Northwest of Iran

Authors: Davoud Adham, Shahram Habibzadeh, Hassan Ghobadi, Shabnam Asghari Jajin, Abbas Abbasi-Ghahramanloo, Eslam Moradi-Asl

Published in: BMC Emergency Medicine | Issue 1/2021

Abstract

Background

Coronavirus disease highly contagious, is prevalent in all age and sex groups infecting the respiratory system. The present study seeks to investigate the epidemiology and effective factors in mortality of patients with COVID-19 in Ardabil province, northwestern Iran.

Methods

In a retrospective study, the hospitalized patients with laboratory-diagnosed COVID-19 between February to August 2020 were enrolled. The data registration portal was designated according to Iranian Ministry of Health and Medical Education guidelines. In this portal, demographic information, clinical presentation, laboratory and imaging data were registered for patients in all hospitals in the same format. The Hosmer-Lemeshow strategy was used for variable selection in a multiple model.

Results

Of the patients involved 2812(50.3%) were male and 150 (2.7%) had contact with a confirmed case of COVID-19 in the last 14 days. Pre-existing comorbidity was reported in 1310 (23.4%) patients. Of all patients, 477(8.5%) died due to COVID-19. the result of the multiple logistic regression model indicated that after adjusting for other factors, higher age (OR = 3.11), fever or chills (OR = 1.61), shortness of breath (OR = 1.82), fatigue (OR = 0.71), headache (OR = 0.64), runny nose (OR = 1.54), Skeletal muscle pain (OR = 1.53), hospitalization (OR = 5.66), and hospitalization in ICU (OR = 5.12) were associated with death.

Conclusions

Hospitalization had the strongest effect on mortality followed by hospitalization in ICU, and higher age. This study showed that having some extra-pulmonary symptoms in contrast with pulmonary symptoms can predict as good prognostic factors.

Chan JF-W, To KK-W, Tse H, Jin D-Y, Yuen K-Y. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 2013;21(10):544–55. https://doi.org/10.1016/j.tim.2013.05.005.CrossRefPubMedPubMedCentral

He J, Tao H, Yan Y, Huang S-Y, Xiao Y. Molecular mechanism of evolution and human infection with the novel coronavirus (2019-nCoV). Viruses. 2020;12(4):428. https://doi.org/10.3390/v12040428.CrossRefPubMedCentral

Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L. Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin nature. 2020;579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7.CrossRefPubMed

Boccia S, Ricciardi W, Ioannidis JP. What other countries can learn from Italy during the COVID-19 pandemic. JAMA Intern Med. 2020;180(7):927–8. https://doi.org/10.1001/jamainternmed.2020.1447.CrossRefPubMed

Lai C-C, Liu YH, Wang C-Y, Wang Y-H, Hsueh S-C, Yen M-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARSCoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53(3):402–12.

Organization WH. Coronavirus disease ( COVID-19): weekly epidemiological update1. 2020;1.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. Jama. 2020;323(20):2052–9. https://doi.org/10.1001/jama.2020.6775.CrossRefPubMedPubMedCentral

Gold JA. Characteristics and clinical outcomes of adult patients hospitalized with COVID-19—Georgia, march 2020. MMWR Morb Mortal Wkly Rep. 2020;69(18):545–50. https://doi.org/10.15585/mmwr.mm6918e1.CrossRefPubMedPubMedCentral

Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. N Engl J Med. 2020;382(24):2372–4. https://doi.org/10.1056/NEJMc2010419.CrossRefPubMed

10.

Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in new York City: a prospective cohort study. Lancet. 2020;395(10239):1763–70. https://doi.org/10.1016/S0140-6736(20)31189-2.CrossRefPubMedPubMedCentral

11.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China The lancet. 2020;395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5.CrossRef

12.

W-j G, Z-y N. Hu Y, Liang W-h, Ou C-q, He J-x, et al. clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020;382:1708–20.

13.

Xu Z, Peng C, Shi Y, Zhu Z, Mu K, Wang X, et al. Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation. bioRxiv 2020 101101/20200127921627. 2020.

14.

Tai DY. Pharmacologic treatment of SARS: current knowledge and recommendations. ANNALS-ACADEMY OF MEDICINE SINGAPORE. 2007;36(6):438.

15.

Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252–6. https://doi.org/10.1136/thorax.2003.012658.CrossRefPubMedPubMedCentral

16.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China Jama. 2020;323(11):1061–9. https://doi.org/10.1001/jama.2020.1585.CrossRefPubMed

17.

Jewell NP. Statistics for epidemiology: CRC press; 2003. https://doi.org/10.1201/9781482286014.CrossRef

18.

Chang D, Lin M, Wei L, Xie L, Zhu G, Cruz CSD, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan. China. Jama. 2020;323(11):1092–3. https://doi.org/10.1001/jama.2020.1623.CrossRefPubMed

19.

Biagi A, Rossi L, Malagoli A, Zanni A, Sticozzi C, Comastri G, et al. Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study. J Med Virol. 2020;92(11):2718–24. https://doi.org/10.1002/jmv.26147.CrossRefPubMed

20.

Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: a single center study. J Clin Virol. 2020;127:104378. https://doi.org/10.1016/j.jcv.2020.104378.CrossRefPubMedPubMedCentral

21.

Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–81. https://doi.org/10.1016/S2213-2600(20)30079-5.CrossRefPubMedPubMedCentral

22.

Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest. 2020;158(1):97–105. https://doi.org/10.1016/j.chest.2020.04.010.CrossRefPubMed

23.

Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–8. https://doi.org/10.1016/j.jaci.2020.04.006.CrossRefPubMedPubMedCentral

24.

Sepandi M, Taghdir M, Alimohamadi Y, Afrashteh S, Hosamirudsari H. Factors associated with mortality in COVID-19 patients: a systematic review and meta-analysis. Iran J Public Health. 2020;49(7):1211–21. https://doi.org/10.18502/ijph.v49i7.3574.CrossRefPubMedPubMedCentral

25.

Iftime S, López-Azcona AF, Vicente-Miralles M, Descarrega-Reina R, Hernández-Aguilera A, Riu F, et al. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain. PloS one. 2020;15(9):e0234452.

26.

Carrillo-Vega MF, Salinas-Escudero G, Garcia-Peña C, Gutierrez-Robledo LM, Parra-Rodriguez L. Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in Mexico. PLoS One. 2020;15(10):e0240394.CrossRef

Title: Epidemiological characteristics and mortality risk factors among COVID-19 patients in Ardabil, Northwest of Iran
Authors: Davoud Adham
Shahram Habibzadeh
Hassan Ghobadi
Shabnam Asghari Jajin
Abbas Abbasi-Ghahramanloo
Eslam Moradi-Asl
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Myalgie
Myalgia
COVID-19
Headache
Published in: BMC Emergency Medicine / Issue 1/2021
Electronic ISSN: 1471-227X
DOI: https://doi.org/10.1186/s12873-021-00463-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Epidemiological characteristics and mortality risk factors among COVID-19 patients in Ardabil, Northwest of Iran

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Prognostic scores and early management of septic patients in the emergency department of a secondary hospital: results of a retrospective study

Experience of using video support by prehospital emergency care physician in ambulance care - an interview study with prehospital emergency nurses in Sweden

Laypeople perception and interpretation of simulated life-threatening bleeding: a controlled experimental study

A dangerously underrated entity? Non-specific complaints at emergency department presentation are associated with utilisation of less diagnostic resources

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department

Data from emergency medicine palliative care access (EMPallA): a randomized controlled trial comparing the effectiveness of specialty outpatient versus telephonic palliative care of older adults with advanced illness presenting to the emergency department